Leidos picks up $23.7M contract to help combat malaria

Leidos has won a $23.7 single award contract to provide scientific and management support for USAID’s Malaria Vaccine Development Program.

USAID’s Malaria Vaccine Development Program aims to develop an efficient, cost-effective malaria vaccine.

Under the contract, Leidos will implement research and development projects to support the program’s mission. Leidos will also provide vaccine concept development and actualization and vaccine evaluations in the preclinical, clinical and field stages of development, the company said in a release.

Leidos is ranked No. 16 on the 2015 Washington Technology Top 100 list of the largest government contractors.

About the Author

Mark Hoover is a senior staff writer with Washington Technology. You can contact him at, or connect with him on Twitter at @mhooverWT.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.


contracts DB